Therapeutic Coordination Polymers: Tailoring Drug Release through Metal-Ligand Interactions

Vedran Nicholas Vukotic,Jennifer Murphy,Joy-Lynn Kobti,Michelle Dao,Darcy Wear,Michael Okoko,S. Pandey
DOI: https://doi.org/10.1039/d4sc00732h
IF: 8.4
2024-04-12
Chemical Science
Abstract:Developing tunable materials which exhibit sustained drug release is a considerable challenge. Herein, we report the concept of Therapeutic Coordination Polymers (TCPs); non-porous coordination polymers constructed from biocompatible components which demonstrate tunable zero-order drug release kinetics upon degradation of metal-ligand bonds. TCPs were constructed from three principal components: i) a cationic metal center (M = Mg 2+ , Mn 2+ , Zn 2+ , or Cu 2+ ); ii) an anionic drug (Diclofenac); and iii) an alkyl bis-imidazole organic ligand which behaves as a "linker" between metal centers. Most drug-release materials, such as amorphous polymer dispersions, or metal-organic frameworks rely on a diffusion-based mechanism for drug release, but the degradation-controlled release of drugs from non-porous one-periodic coordination polymers has been largely unexplored. TCPs described herein exhibit a high wt.% of pharmaceutical (>62%), tailorable zero-order drug release rate kinetics which span over three orders of magnitude, and stimuli-responsive drug release behavior making them well suited for exteded drug-release applications.
chemistry, multidisciplinary
What problem does this paper attempt to address?